Literature DB >> 11861040

Sex hormones and hypertension.

Raghvendra K Dubey1, Suzanne Oparil, Bruno Imthurn, Edwin K Jackson.   

Abstract

Gender has an important influence on blood pressure, with premenopausal women having a lower arterial blood pressure than age-matched men. Compared with premenopausal women, postmenopausal women have higher blood pressures, suggesting that ovarian hormones may modulate blood pressure. However, whether sex hormones are responsible for the observed gender-associated differences in arterial blood pressure and whether ovarian hormones account for differences in blood pressure in premenopausal versus postmenopausal women remains unclear. In this review, we provide a discussion of the potential blood pressure regulating effects of female and male sex hormones, as well as the cellular, biochemical and molecular mechanisms by which sex hormones may modify the effects of hypertension on the cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861040     DOI: 10.1016/s0008-6363(01)00527-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  134 in total

1.  Gender Based Differences in Risk Factor Profile and Coronary Angiography of Patients Presenting with Acute Myocardial Infarction in North Indian Population.

Authors:  Supriya Bajaj; Vijay Mahajan; Sumit Grover; Amit Mahajan; Nipun Mahajan
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  6β-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice.

Authors:  Ajeeth K Pingili; Mehmet Kara; Nayaab S Khan; Anne M Estes; Zongtao Lin; Wei Li; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

3.  Age-related changes in dorsal root ganglia, circulating and vascular calcitonin gene-related peptide (CGRP) concentrations in female rats: effect of female sex steroid hormones.

Authors:  Pandu R R Gangula; Madhu Chauhan; Luckey Reed; Chandra Yallampalli
Journal:  Neurosci Lett       Date:  2009-03-05       Impact factor: 3.046

Review 4.  Failure to consider the menstrual cycle phase may cause misinterpretation of clinical and research findings of cardiometabolic biomarkers in premenopausal women.

Authors:  Enrique F Schisterman; Sunni L Mumford; Lindsey A Sjaarda
Journal:  Epidemiol Rev       Date:  2013-09-15       Impact factor: 6.222

5.  Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.

Authors:  Di Zhao; Eliseo Guallar; Pamela Ouyang; Vinita Subramanya; Dhananjay Vaidya; Chiadi E Ndumele; Joao A Lima; Matthew A Allison; Sanjiv J Shah; Alain G Bertoni; Matthew J Budoff; Wendy S Post; Erin D Michos
Journal:  J Am Coll Cardiol       Date:  2018-06-05       Impact factor: 24.094

6.  Estrogen metabolism by cytochrome P450 1B1 modulates the hypertensive effect of angiotensin II in female mice.

Authors:  Brett L Jennings; L Watson George; Ajeeth K Pingili; Nayaab S Khan; Anne M Estes; Xiao R Fang; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2014-04-28       Impact factor: 10.190

Review 7.  Impact of female hormones on blood pressure: review of potential mechanisms and clinical studies.

Authors:  Jane Morley Kotchen; Theodore A Kotchen
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

8.  Hypertension in women: latest findings and clinical implications.

Authors:  Helga Gudmundsdottir; Aud Høieggen; Aud Stenehjem; Bård Waldum; Ingrid Os
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

9.  Ten-year incidence of hypertension in a Swiss population-based sample Incidence of hypertension in Switzerland.

Authors:  Ana Sofia Quinteiros Fidalgo; Peter Vollenweider; Pedro Marques-Vidal
Journal:  J Hum Hypertens       Date:  2018-10-03       Impact factor: 3.012

Review 10.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.